Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CERTOLIZUMAB PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CERTOLIZUMAB PEGOL: Safety Overview

Metric CEMIPLIMAB CERTOLIZUMAB PEGOL
Total FAERS Reports 1,020 99,098
Deaths Reported 175 5,361
Death Rate 17.2% 5.4%
Hospitalizations 651 17,641
Average Patient Age 68.9 yrs 49.5 yrs
% Female Patients 36.6% 83.1%
Manufacturer Regeneron Pharmaceuticals, Inc. UCB, Inc.
Route INTRAVENOUS SUBCUTANEOUS
Marketing Status N/A Prescription